Recent data from our group (Harryvan et al., in revision) showed that in human colorectal cancer (CRC), in vitro-cultured CAFs acquire enhanced cross-presentation through upregulation of the lysosomal protease cathepsin S, a key component of the vacuolar pathway. The gene discussed is CTSS; the disease is colorectal carcinoma.